Sunshine Biopharma (NASDAQ: SBFM) Enters into Employment Agreements with Key Executives

On October 21, 2024, Sunshine Biopharma Inc. (NASDAQ: SBFM) finalized employment agreements with key executives. Dr. Steve N. Slilaty, the Chief Executiv

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Sunshine Biopharma’s 8K filing here.

About Sunshine Biopharma

(Get Free Report)

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.

Featured Stories